Artal Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Artal Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-850,000	Closed	-$1.12M	–	104
2023 Q3	$1.12M	Hold	850,000	–	–	0.05%	75
2023 Q2	$2.54M	Hold	850,000	–	–	0.08%	81
2023 Q1	$2.94M	Hold	850,000	–	–	0.17%	74
2022 Q4	$3.55M	Hold	850,000	–	–	0.2%	71
2022 Q3	$3.41M	Hold	850,000	–	–	0.15%	75
2022 Q2	$9.61M	Hold	850,000	–	–	0.51%	39
2022 Q1	$13.8M	Hold	850,000	–	–	0.58%	40
2021 Q4	$40.3M	Buy	850,000 +25,000	+3%	+$1.5M	1.09%	26
2021 Q3	$59.8M	Buy	825,000 +75,000	+10%	+$5.42M	1.34%	20
2021 Q2	$63M	Hold	750,000	–	–	1.28%	18
2021 Q1	$36.4M	Buy	750,000 +25,000	+3%	+$1.36M	0.64%	38
2020 Q4	$34.2M	Hold	725,000	–	–	0.73%	37
2020 Q3	$34.1M	Buy	725,000 +401,000	+124%	+$13.2M	0.83%	28
2020 Q2	$9.7M	Sell	324,000 -26,000	-7%	-$538K	0.27%	71
2020 Q1	$4.55M	Buy	+350,000	New	+$4.37M	0.19%	77

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

EPL

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artal Group's NBP Position: Q4 2023 in Review

Artal Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2023, closing a stake of 850,000 shares — an estimated $1.12M sold.

Artal Group first reported a position in NBP in Q1 2020 and held it in 15 quarters. The position peaked at $63M in Q2 2021. 44 funds tracked by Wall St. Rank hold NBP as of Q4 2023.

Artal Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Artal Group sold 850,000 NovaBridge Biosciences American Depositary Shares shares in Q4 2023, an estimated $1.12M.
Artal Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and held it in 15 quarters.
Artal Group's NovaBridge Biosciences American Depositary Shares position peaked at $63M in Q2 2021.
44 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2023.

Based on Artal Group's 13F filing for Q4 2023, filed 9 Feb 2024.